HR 126 Hawaii House · 2026 Regular Session

URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.

This bill is a House resolution urging the Hawaii State Director of Health to allow the sale and purchase of nebulized budesonide without a prescription. It also requests that the Board of Pharmacy adopt rules ensuring proper labeling and usage instructions are provided to consumers. The resolution cites various international studies and health guidelines supporting the use of budesonide for respiratory conditions, particularly in relation to COVID-19 treatment. The measure does not change any laws directly but asks state health officials to issue an order making the medication and nebulizer machines more accessible to the public.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 16, 2026 Last action Mar 18, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 18, 2026
Committee
Referred to HLT, CPC, referral sheet 19
lower
Mar 16, 2026
Introduced
Offered
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of David Alcos
David Alcos
RRepublican
HI
41